"Pharmaceutical Manufacturing Companies Fee. Under this proposal, an annual fee of $2.3 billion would be imposed on the pharmaceutical manufacturing sector beginning in 2010. The fee would be allocated by market share.
"Medical Device Manufacturers Fee. Under this proposal, an annual fee of $4 billion would be imposed on the medical devices manufacturing sector beginning in 2010. The fee would be allocated by market share.
"Clinical Laboratories Fee. Under this proposal, an annual fee of $750 million would be imposed on clinical laboratories beginning in 2010. The fee would be allocated by market share, except for small businesses.
"Regardless, the talking points are a strong signal to life sciences innovators that the health care reform dialogue in Washington is heading in a direction that will directly harm innovation......" and "we can be sure that this will contribute to increasing costs of healthcare, contrary to the national objective.
"However, from every possible perspective, this proposal is a zero-sum gain to the Federal government, and a raw deal being offered to innovators in life sciences."
Read more HERE>
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment